narcistatin

conversion of narciclasine to a cyclic phosphate for a water soluble prodrug

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

1.	Inflammation (Inflammations) 12/01/2012 - "Preclinical efficacy of sodium narcistatin to reduce inflammation and joint destruction in rats with adjuvant-induced arthritis."
2.	Arthritis (Polyarthritis) 12/01/2012 - "Preclinical efficacy of sodium narcistatin to reduce inflammation and joint destruction in rats with adjuvant-induced arthritis."
3.	Neoplasms (Cancer) 01/01/2003 - "Narcistatin (3b) and 15 salt derivatives were evaluated against a panel of human cancer cell lines, and the range (0.1-0.01) of GI(50) values in micro g/mL was found to parallel that shown by the parent narciclasine."